Actavis South Atlantic recalls
Actavis South Atlantic has 3 recalls on record with the FDA and USDA, the earliest in 2013 and the latest reported on 4 Sep 2013. The most frequent reason is potency & assay.
Total recalls3since 2013
Last 12 months0reported
Class I00% of total
Ongoing0latest 4 Sep 2013
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 33%Class III 2 67%
Why actavis south atlantic is recalled
Product types
By year
All actavis south atlantic recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | buPROPion Hydrochloride Extended-Release Tablets (XL) recalled | Actavis South Atlantic | Potency & Assay | Nationwide |
| Drug | CLASS II | Ranitidine Syrup (Ranitidine Oral Solution USP) 15 mg/mL recalled | Actavis South Atlantic | Potency & Assay | Nationwide |
| Drug | CLASS III | buPROPion Hydrochloride Extended-Release Tablets (XL) recalled | Actavis South Atlantic | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.